Piwowarski Jakub P, Granica Sebastian, Zwierzyńska Marta, Stefańska Joanna, Schopohl Patrick, Melzig Matthias F, Kiss Anna K
Department of Pharmacognosy and Molecular Basis of Phytotherapy, Medical University of Warsaw, Faculty of Pharmacy, Banacha 1, 02-097 Warsaw, Poland.
Department of Pharmacognosy and Molecular Basis of Phytotherapy, Medical University of Warsaw, Faculty of Pharmacy, Banacha 1, 02-097 Warsaw, Poland.
J Ethnopharmacol. 2014 Aug 8;155(1):801-9. doi: 10.1016/j.jep.2014.06.032. Epub 2014 Jun 23.
Ellagitannin-rich plant materials are widely used in traditional medicine as effective, internally used anti-inflammatory agents. Due to the not well-established bioavailability of ellagitannins, the mechanisms of observed therapeutic effects following oral administration still remain unclear. The aim of the study was to evaluate if selected ellagitannin-rich plant materials could be the source of bioavailable gut microbiota metabolites, i.e. urolithins, together with determination of the anti-inflammatory activity of the metabolites produced on the THP-1 cell line derived macrophages model.
The formation of urolithins was determined by ex vivo incubation of human fecal samples with aqueous extracts from selected plant materials. The anti-inflammatory activity study of metabolites was determined on PMA differentiated, IFN-γ and LPS stimulated, human THP-1 cell line-derived macrophages.
The formation of urolithin A, B and C by human gut microbiota was established for aqueous extracts from Filipendula ulmaria (L.) Maxim. herb (Ph. Eur.), Geranium pratense L. herb, Geranium robertianum L. herb, Geum urbanum L. root and rhizome, Lythrum salicaria L. herb (Ph. Eur.), Potentilla anserina L. herb, Potentilla erecta (L.) Raeusch rhizome (Ph. Eur.), Quercus robur L. bark (Ph. Eur.), Rubus idaeus L. leaf, Rubus fruticosus L. and pure ellagitannin vescalagin. Significant inhibition of TNF-α production was determined for all urolithins, while for the most potent urolithin A inhibition was observed at nanomolar concentrations (at 0.625 μM 29.2±6.4% of inhibition). Urolithin C was the only compound inhibiting IL-6 production (at 0.625 μM 13.9±2.2% of inhibition).
The data obtained clearly indicate that in the case of peroral use of the examined ellagitannin-rich plant materials the bioactivity of gut microbiota metabolites, i.e. urolithins, has to be taken under consideration.
富含鞣花单宁的植物材料在传统医学中被广泛用作有效的内服抗炎剂。由于鞣花单宁的生物利用度尚未完全明确,口服给药后观察到的治疗效果机制仍不清楚。本研究的目的是评估所选富含鞣花单宁的植物材料是否可能是生物可利用的肠道微生物群代谢产物(即尿石素)的来源,并测定在源自THP-1细胞系的巨噬细胞模型上产生的代谢产物的抗炎活性。
通过将人粪便样本与所选植物材料的水提取物进行体外孵育来测定尿石素的形成。在经佛波酯分化、干扰素-γ和脂多糖刺激的源自人THP-1细胞系的巨噬细胞上进行代谢产物的抗炎活性研究。
已确定来自绣线菊(欧洲药典)、草原老鹳草、罗伯特老鹳草、林地水杨梅根状茎、千屈菜(欧洲药典)、鹅绒委陵菜、委陵菜(欧洲药典)、欧洲栓皮栎(欧洲药典)、覆盆子叶、欧洲黑莓和纯鞣花单宁vescalagin的水提取物可通过人体肠道微生物群形成尿石素A、B和C。所有尿石素均能显著抑制肿瘤坏死因子-α的产生,而对于最有效的尿石素A,在纳摩尔浓度下观察到抑制作用(在0.625μM时抑制率为29.2±6.4%)。尿石素C是唯一抑制白细胞介素-6产生的化合物(在0.625μM时抑制率为13.9±2.2%)。
所获得的数据清楚地表明,在口服使用所研究的富含鞣花单宁的植物材料时,必须考虑肠道微生物群代谢产物(即尿石素)的生物活性。